In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $25.06 in the prior trading day, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $24.23, down -3.31%. In other words, the price has decreased by -$3.31 from its previous closing price. On the day, 2.17 million shares were traded. BEAM stock price reached its highest trading level at $25.805 during the session, while it also had its lowest trading level at $23.94.
Ratios:
Our goal is to gain a better understanding of BEAM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Leerink Partners Upgraded its Market Perform to Outperform on November 06, 2024, whereas the target price for the stock was revised from $27 to $39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 18 ’25 when Cavanagh Bethany J sold 6,287 shares for $35.00 per share. The transaction valued at 220,045 led to the insider holds 37,527 shares of the business.
Bellon Christine sold 10,000 shares of BEAM for $340,000 on Feb 14 ’25. The Chief Legal Officer now owns 102,968 shares after completing the transaction at $34.00 per share. On Feb 14 ’25, another insider, CHRISTINE BELLON, who serves as the Officer of the company, bought 10,000 shares for $34.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2419123200 and an Enterprise Value of 1276015232. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.08 while its Price-to-Book (P/B) ratio in mrq is 2.76. Its current Enterprise Value per Revenue stands at 20.089 whereas that against EBITDA is -3.242.
Stock Price History:
The Beta on a monthly basis for BEAM is 1.89, which has changed by -0.28871274 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $37.42, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -10.03%, while the 200-Day Moving Average is calculated to be -6.17%.
Shares Statistics:
The stock has traded on average 1.51M shares per day over the past 3-months and 2790840 shares per day over the last 10 days, according to various share statistics. A total of 99.84M shares are outstanding, with a floating share count of 88.04M. Insiders hold about 11.82% of the company’s shares, while institutions hold 69.87% stake in the company. Shares short for BEAM as of 1740700800 were 9992985 with a Short Ratio of 6.62, compared to 1738281600 on 10015050. Therefore, it implies a Short% of Shares Outstanding of 9992985 and a Short% of Float of 15.57.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
